Table 4.
Serum viral markers in two groups (cases) before treatment.
| Group | n | HBsAg | HBsAb | HBeAg | HBeAb | HBcAb | HBcAb-IM | HBV-DNA |
| Experimental | 110 | 110 | 3 | 48 | 48 | 105 | 40 | 38 |
| Control | 106 | 106 | 2 | 48 | 56 | 100 | 35 | 37 |
| P | 1.000 | 0.891 | 0.220 | 0.765 | 0.659 | 1.000 |
Serum viral markers in two groups (cases) before treatment.
| Group | n | HBsAg | HBsAb | HBeAg | HBeAb | HBcAb | HBcAb-IM | HBV-DNA |
| Experimental | 110 | 110 | 3 | 48 | 48 | 105 | 40 | 38 |
| Control | 106 | 106 | 2 | 48 | 56 | 100 | 35 | 37 |
| P | 1.000 | 0.891 | 0.220 | 0.765 | 0.659 | 1.000 |